Aurora Cannabis Inc. (NASDAQ:ACB) Short Interest Update

Aurora Cannabis Inc. (NASDAQ:ACB) was the recipient of a significant drop in short interest in the month of September. As of September 30th, there was short interest totalling 2,590,000 shares, a drop of 5.1% from the September 15th total of 2,730,000 shares. Currently, 4.8% of the shares of the company are sold short. Based on an average daily volume of 1,280,000 shares, the days-to-cover ratio is presently 2.0 days.

Institutional Trading of Aurora Cannabis

Several institutional investors have recently bought and sold shares of ACB. Cubist Systematic Strategies LLC acquired a new position in Aurora Cannabis during the second quarter worth $50,000. Cetera Advisors LLC acquired a new stake in shares of Aurora Cannabis during the 1st quarter worth about $59,000. Toronto Dominion Bank lifted its holdings in Aurora Cannabis by 34,356.4% during the 2nd quarter. Toronto Dominion Bank now owns 18,951 shares of the company’s stock valued at $88,000 after purchasing an additional 18,896 shares during the last quarter. Concurrent Investment Advisors LLC acquired a new position in Aurora Cannabis in the first quarter valued at about $90,000. Finally, Baader Bank Aktiengesellschaft grew its stake in Aurora Cannabis by 121.1% during the second quarter. Baader Bank Aktiengesellschaft now owns 22,789 shares of the company’s stock worth $100,000 after buying an additional 12,481 shares during the last quarter. Institutional investors and hedge funds own 47.63% of the company’s stock.

Aurora Cannabis Price Performance

NASDAQ:ACB opened at $5.59 on Friday. The company has a debt-to-equity ratio of 0.08, a quick ratio of 2.03 and a current ratio of 3.76. The company has a 50-day moving average of $5.88 and a 200-day moving average of $6.07. Aurora Cannabis has a 52 week low of $2.84 and a 52 week high of $9.35. The company has a market capitalization of $304.91 million, a price-to-earnings ratio of -3.99 and a beta of 1.86.

Aurora Cannabis (NASDAQ:ACB) last announced its quarterly earnings results on Wednesday, August 7th. The company reported ($0.11) EPS for the quarter, topping analysts’ consensus estimates of ($0.35) by $0.24. Aurora Cannabis had a negative net margin of 14.46% and a negative return on equity of 7.00%. The firm had revenue of $67.27 million during the quarter, compared to analysts’ expectations of $55.98 million. As a group, equities research analysts anticipate that Aurora Cannabis will post -0.37 earnings per share for the current fiscal year.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.